Abstract:Objective To investigate the efficacy of chitosan hemostatic powder in the treatment of superficial skin injury in officers and soldiers. Methods A total of 102 soldiers who suffered superficial skin injuries during special operations and mobile training from June 2019 to May 2022 were randomly divided into test group and control group according to their certificate number, and were also divided into hand injury group and body injury group according to different injury sites. The wounded in all the groups were treated with iodophor and exposed to the affected areas. The test group was treated with chitosan hemostatic powder to form scabs naturally for dry healing. The pain of the patients treated with iodophor and chitosan was compared, and the time of scab formation and scab shedding was compared between the two groups under different injury sites. Results After the application of chitosan hemostatic powder, the pain degree was mild and the tolerance was good. The duration of scab in the hand injury test group [(12.89±5.33) h]was significantly shorter than that in the hand injury control group[ (16.36±4.77) h], and the difference was statistically significant (P<0.05). The duration of scab formation[ (21.14±10.38) h] and the duration of scab removal[(15.14±1.51 ) d] in the body injury test group were significantly shorter than those in the control group[(28.50±11.86) h and (17.44±2.25) d], and the difference was statistically significant (P<0.05). Conclusions Chitosan hemostatic powder is effective in the treatment of superficial skin, which is characterized by fast scab, less pain and fast healing.
Patrulea V, Ostafe V, Borchard G, et al. Chitosan as a starting material for wound healing applications[J]. Eur J Pharm Biopharm, 2015,97(Pt B):417-426.
[2]
Liu H, Wang C, Li C, et al. A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing[J]. RSC Adv, 2018,8(14):7533-7549.
[3]
Hosseinnejad M, Jafari S M. Evaluation of different factors affecting antimicrobial properties of chitosan[J]. Int J Biol Macromol, 2016, 85:467-475.
[4]
Chung Y J, An S Y, Yeon J Y, et al. Effect of a chitosan gel on hemostasis and prevention of adhesion after endoscopic sinus surgery[J]. Clin Exp Otorhinolaryngol, 2016, 9(2):143-149.
[5]
Azad A K, Sermsintham N, Chandrkrachang S, et al. Chitosan membrane as a wound-healing dressing: characterization and clinical application[J]. J Biomed Mater Res B Appl Biomater, 2004,69(2):216-222.
[6]
Halim A S, Nor F M, Mat Saad A Z, et al. Efficacy of chitosan derivative films versus hydrocolloid dressing on superficial wounds[J]. J Taibah Univ Med Sci, 2018,13(6):512-520.
[7]
Bachtell N, Goodell T, Grunkemeier G, et al. Treatment of dialysis access puncture wound bleeding with chitosan dressings[J]. Dial Transpl, 2010,35(11):672-681.
[8]
Campani V, Pagnozzi E, Mataro I, et al. Chitosan gel to treat pressure ulcers: a clinical pilot study[J]. Pharmaceutics, 2018,10(1):12-20.
[9]
Wedmore I, McManus J G, Pusateri A E, et al. A special report on the chitosan-based hemostatic dressing: experience in current combat operations[J]. J Trauma, 2006, 60(3): 655-658.
[10]
Te Grotenhuis R, van Grunsven P M, Heutz W M, et al. Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: a prospective study of 66 cases[J]. Injury, 2016,47(5):1007-1011.
[11]
Otrocka-Domagała I, Jastrzębski P, Adamiak Z, et al. Safety of the long-term application of Quik Clot Combat Gauze, ChitoGauze PRO and Celox Gauze in a femoral artery injury model in swine-a preliminary study[J]. Pol J Vet Sci, 2016,19(2):337-343.
[12]
Haque M I, Beekley A C, Gutowska A, et al. Bioabsorption qualities of chitosan-absorbable vascular templates(1)[J]. Curr Surg, 2001,58(1):77-80.